<DOC>
	<DOCNO>NCT01363791</DOCNO>
	<brief_summary>Diabetes heart association continue discourage high intake dietary fructose , constituent part sucrose molecule find fruit vegetable natural sugar process food beverage add sweetener . The concern relate ability increase certain blood fat cholesterol , increase risk cardiovascular disease . The evidence adverse effect fructose risk factor , however , inconclusive . To improve evidence nutrition recommendation fructose base , investigator therefore propose study effect fructose blood fat , cholesterol , sugar , blood pressure , body weight , undertake systematic synthesis data take available clinical study human . This technique strength allow available data pool together difference explore group different study participant ( healthy human different sex , weight , age disease predispose disturbance metabolism , diabetes ) dietary fructose different form , dos , differ duration exposure . The finding generate propose knowledge synthesis help improve health consumer inform recommendation general public , well risk diabetes cardiovascular disease .</brief_summary>
	<brief_title>Meta-analyses Fructose Cardiometabolic Risk</brief_title>
	<detailed_description>Background : Fructose implicate chronic disease guideline . The American Heart Association ( AHA ) American ( ADA ) , Canadian ( CDA ) , European ( EASD ) Diabetes Associations discourage dietary fructose high intake ( &gt; 15-20 % energy ) , cite ability aggravate blood lipid . The American Heart Association ( AHA ) World Health Organization ( WHO ) recommend reduce consumption ( &lt; 5-7 % &lt; 10 % energy , respectively ) add sugar , especially high fructose corn syrup sugar sweeten beverage , decrease risk weight gain . These concern , however , base inconsistent intervention data human . There also paradoxical evidence small , catalytic dos fructose level obtainable fruit ( &lt; 10-g/meal ) may improve glycemic control human . Objective : To improve evidence-based guidance fructose recommendation , investigator propose conduct series 7 systematic review meta-analyses control feed trial assess effect oral fructose cardiometabolic risk human . The first 6 systematic review meta-analyses conduct different area cardiometabolic risk : ( 1 ) lipid , ( 2 ) glycemic control , ( 3 ) body weight , ( 4 ) uric acid , ( 5 ) blood pressure , ( 6 ) non-alcoholic fatty liver ( NAFL ) . The seventh meta-analysis investigate effect small , `` catalytic '' dos fructose level obtainable fruit ( &lt; 10-g/meal ) area cardiometabolic risk . Design : The planning conduct propose meta-analyses follow Cochrane handbook systematic review intervention . The reporting follow Preferred Reporting Items Systematic review Meta-Analyses ( PRISMA ) guideline . Data source . MEDLINE , EMBASE , CINAHL The Cochrane Central Register Controlled Trials ( Clinical Trials ; CENTRAL ) search use appropriate search term , supplement manual , hand search bibliography . Study selection : We include controlled feeding trial investigate effect fructose isocaloric exchange carbohydrate source ( isocaloric trial ) add control diet source excess energy ( hypercaloric trial ) cardiometabolic risk factor human . Studies &lt; 7-days diet duration , lack control , provide viable endpoint data exclude . To isolate effect fructose , also exclude trial fructose administer exclusively sucrose ( bound fructose ) high-fructose corn syrup ( 42 % 55 % free fructose ) , except sweetener comparator . Data extraction . Two investigator independently extract information study design , sample size , subject characteristic , fructose form , dose , reference-carbohydrate , follow-up , background diet profile . Mean±SEM value extract outcomes . Standard computation imputation use derive miss variance data . Investigators assess quality/validity study use Heyland Methodological Quality Score ( MQS ) . Outcomes : The first 6 7 propose analysis assess set outcomes related different area cardiometabolic risk : ( 1 ) lipid ( fast lipid [ triglyceride , HDL-cholesterol [ C ] , LDL-C , apo-B , total-C : HDL-C ratio , apo-B : apo-A1 ratio , non-HDL-C ] postprandial lipid ( non-fasting peak , mean , area curve [ AUC ] triglyceride ) , ( 2 ) glycemic control ( fast glucose insulin , glycated blood protein ) insulin sensitivity ( Euglycemic-hyperinsulinemic clamp , frequent sample intravenous glucose tolerance test [ FSIGT ] , Homeostasis model assessment insulin resistance [ HOMA-IR ] , oral glucose tolerance test insulin sensitivity index [ OGTT-ISI ] ) , ( 3 ) body weight , ( 4 ) uric acid , ( 5 ) blood pressure ( systolic BP , diastolic BP , mean arterial pressure ) , ( 6 ) NAFL ( image spectroscopy endpoint liver fat biomarkers hepatocellular injury [ transaminases ] ) . The last proposed analysis investigate effect small , `` catalytic '' dos fructose focus 6 outcome . Data synthesis . Meta-analyses conduct use Generic Inverse Variance method apply random effect model express standardized mean difference ( SMDs ) 95 % CIs . Paired analyse apply crossover trial accord Elbourne et al . ( Int J Epidemiol . 2002 ; 31:140-149 ) . Heterogeneity assess Q statistic quantify I2 . A priori subgroup analyse undertaken explore source heterogeneity include effect underlie disease status , reference carbohydrate ( comparator ) , fructose form , dose , follow-up , study design , baseline measurement , study quality effect fructose . Significant unexplained heterogeneity investigate additional post hoc subgroup analysis ( e.g . age , sex , level feeding control , energy balance composition background diet , etc . ) sensitivity analysis . Meta-regression analysis assess significance subgroup analyse piece-wise meta-regression technique use identify dose follow-up threshold . Publication bias investigate inspection funnel plot . Knowledge translation plan : The result disseminate interactive presentation local , national , international scientific meeting publication high impact factor journal . Target audience include public health scientific community interest nutrition , diabetes , obesity , cardiovascular disease . Feedback incorporate use improve public health message key area future research define . Applicant/Co-applicant Decision Makers network among opinion leader increase awareness participate directly committee member development future guideline . Preliminary finding : A pilot project explore effect fructose lipid diabetes identified 786 article , 14 ( 16 trial ) include meta-analysis . Isocaloric exchange fructose carbohydrate triglyceride raise effect type 2 diabetes reference carbohydrate starch , dose &gt; 60-g/d , follow-up ≤4-weeks . These distinction appreciate previously ( Sievenpiper et al . Diabetes Care 2009 ; 32:1930-1937 ) . Significance : The propose project aid knowledge translation relate effect dietary fructose diabetes , cardiovascular risk factor , strengthen evidence-base recommendation improve health outcome inform consumer guide future research .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Trials human Oral fructose intervention Suitable control ( i.e . another carbohydrate source isocaloric exchange fructose control diet compare diet supplemented excess energy fructose ) &gt; = 7days diet duration Viable endpoint data Nonhuman study IV parenteral fructose High fructose corn syrup sucrose intervention ( except comparators ) Lack suitable control &lt; 7days diet duration . No viable endpoint data</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Systematic review meta-analysis</keyword>
	<keyword>Evidence-based medicine ( EBM )</keyword>
	<keyword>Evidence-based nutrition ( EBN )</keyword>
	<keyword>Clinical practice guideline</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Dietary sugar</keyword>
	<keyword>Fructose</keyword>
	<keyword>High fructose corn syrup</keyword>
	<keyword>Fruit</keyword>
	<keyword>Isocaloric</keyword>
	<keyword>Hypercaloric</keyword>
	<keyword>Cardiometabolic risk factor</keyword>
	<keyword>Triglycerides</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>Glycemic control</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Body weight</keyword>
	<keyword>Uric acid</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Fatty liver</keyword>
	<keyword>Fasting</keyword>
	<keyword>Postprandial</keyword>
</DOC>